Software house Brady taking on staff as it sees new contracts ahead

Commodity trading software supplier Brady plc (BRY.L) said today that it was taking on extra staff to cope with consulting work associated with customers' installing of its flagship Trinity system.

The company said in a trading update to coincide with today's Annual General Meeting that the directors are "cautiously optimistic on achieving further contract signatures during 2006".

The news drove its shares up 8.3%, or 2p, to 26p, taking market capitalisation to £6.6m and providing some relief from a steady decline. For it most recent financial year to end December it reported a 50% fall in sales, as the roll out of its key product upgrade was delayed by changes to specifications sought by a major customer.

There has also been uncertainty around a major legal battle. The company said is no update in relation to the Sempra Metals Ltd claim and its counter claim. London-based trading and broking firm Sempra issued a claim against Brady in the High Court late last year for damages of £3.1m for alleged breaches of contract by Brady regarding a software development contract. Brady said earlier that a substantive defence was being prepared and that it intends to counter claim for fees payable under the software contract and damages in the order of £2.9m.

Clients invite proposals

But there has been some good news this year. On 1st March Brady said it had secured a new contract with one of the largest copper producers in the world. Since then, it said other large organisations have asked it to make detailed contract proposals and it is currently working on paid scoping exercises for a number of them.

Brady said a project to implement its Trinity software package is typically planned over several phases because of the large number of business areas that are covered by the product, including front office, risk management, back office, accounting, and supply chain logistics.

"Implementation of the product typically involves significant paid professional services work" it said, so it has begun limited recruitment to ensure it maintains adequate staffing levels for the expected level of business going forward.

The firm's accounting policy is to recognise licence fees predominantly towards the end of projects or phases, and therefore new contract signatures will typically have their largest positive financial impact 6 to 12 months after signature.

4th May 2006


Previous articles
ANT revenues grow, losses narrow as the way media content is viewed morphs
CSR reports strong Q307 growth; launches cheap internet radio chip
Cybit buys Bluefinger for £1.62m in scrip, warrants
Clinical Cell Culture beefs up management in Q2, switches focus to sales
nCipher agrees to £51m takeover offer from Thales
Stem Cell Sciences’ losses widen in 07; sees marketing delivering revenue growth in 08
Plastic Logic closes in on pilot production for 'disruptive' high-res plastic e-readers
Briefs: Meldex puts German subsidiary into receivership; CSR launches new wireless chips
Cytomyx sells subsidiary; to focus on US biorepository business
New Snippets: Cambridge Consultants wins major VOIP contract; new FD at CSR
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Cambridge Biostability


Bruce Roser
Chief Scientific Adviser


Cambridge Biostability Ltd is a privately held company founded in 1998 with a combination of investor funding and project financing. It has a portfolio of patents and is entering into a number of agreements to licence and provide outsourced production of thermo-stable liquid vaccines and drugs. Development

[Cambridge Biostability's profile]


Top20 Index




Currently: 161.56